Disease severity and prefrontal cortex activation during obstacle negotiation among patients with Parkinson's disease: Is it all as expected?

被引:1
|
作者
Assad, M. [1 ,2 ]
Galperin, I [1 ,2 ]
Giladi, N. [1 ,3 ,4 ]
Mirelman, A. [1 ,3 ,4 ]
Hausdorff, J. M. [1 ,4 ,5 ,6 ,7 ]
Maidan, I [1 ,3 ,4 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Lab Early Markers Neurodegenerat, Ctr Study Movement Cognit & Mobil, Neurol Inst, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel
[4] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel
[6] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA
[7] Rush Univ, Med Ctr, Dept Orthopaed Surg, Chicago, IL USA
基金
以色列科学基金会;
关键词
Prefrontal cortex; fNIRS; Obstacle negotiation; Available response time; BRAIN ACTIVATION; COMPLEX WALKING; OLDER-ADULTS; ATTENTION; SIZE;
D O I
10.1016/j.parkreldis.2022.06.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Previous reports indicate that patients with Parkinson's disease (PD) activate the prefrontal cortex (PFC) during complex activities such as obstacle negotiation to compensate for impaired motor function. However, the influence of disease severity on PFC activation has not been systematically evaluated. Here, we examined the effects of disease severity on PFC activation during obstacle negotiation. Methods: 74 patients with PD (age 68.26 +/- 7.54 yrs; 62.2% men) were divided into three groups based on Hoehn and Yahr stages. All patients walked along an obstacle course while negotiating anticipated and unanticipated obstacles (long/low available response time) at heights of 50 mm and 100 mm. PFC activation was measured using functional near-infrared spectroscopy (fNIRS) and was compared between groups and tasks using mixed model analyses. Results: Participants with more advanced PD (i.e., Hoehn & Yahr 3) had higher PFC activation levels when negotiating anticipated obstacles, compared to participants with milder PD (i.e., Hoehn & Yahr 1, 2) (p < 0.001). Moreover, higher LEDD correlated with higher prefrontal activation during the higher anticipated obstacle. In contrast, during the negotiation of unanticipated obstacles, the differences in PFC activation were not associated with disease severity in a linear manner. Conclusions: The present study suggests that with increased disease severity, patients with PD rely more on the PFC when negotiating anticipated obstacles, perhaps to compensate for attention and motor deficits. These findings support the role of cognition in fall risk and the need to improve attention and cognition in fall prevention programs, especially among patients with more advanced disease.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 50 条
  • [31] Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease
    del Olmo, Miguel Fernandez
    Bello, Olalla
    Cudeiro, Javier
    CLINICAL NEUROPHYSIOLOGY, 2007, 118 (01) : 131 - 139
  • [32] Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease
    Lanoue, Amelie C.
    Blatt, Gene J.
    Soghomonian, Jean-Jacques
    BRAIN RESEARCH, 2013, 1531 : 37 - 47
  • [33] SLEEP DISTURBANCE, MOOD, AND DISEASE SEVERITY IN PATIENTS WITH PARKINSON'S DISEASE
    Brown, Rashelle E.
    Vrana, Scott
    ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S98 - S98
  • [34] Changes in facial expressions in patients with Parkinson's disease during the phonation test and their correlation with disease severity
    Yang, Liqiong
    Chen, Xiangling
    Guo, Quanhao
    Zhang, Jing
    Luo, Man
    Chen, Xiaqing
    Wen, Yanxia
    Zou, Xianwei
    Xu, Fan
    COMPUTER SPEECH AND LANGUAGE, 2022, 72
  • [35] Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease
    Herz, Damian M.
    Siebner, Hartwig R.
    Hulme, Oliver J.
    Florin, Esther
    Christensen, Mark S.
    Timmermann, Lars
    NEUROIMAGE, 2014, 90 : 15 - 23
  • [36] Prevalence of Fabry disease among patients with Parkinson's disease
    Mosejova, A.
    Oppermann, S.
    Han, V.
    Dosekova, P.
    Cobejova, J.
    Cobej, M.
    Levicka, P.
    Liesenerova, S.
    Lorincova, T.
    Ostrozovicova, M.
    Sendekova, D.
    Sukovska, V.
    Gdovinova, Z.
    Bauer, P.
    Skorvanek, M.
    MOVEMENT DISORDERS, 2019, 34 : S187 - S187
  • [37] Prevalence of Fabry Disease among Patients with Parkinson's Disease
    Lackova, Alexandra
    Beetz, Christian
    Oppermann, Sebastian
    Bauer, Peter
    Pavelekova, Petra
    Lorincova, Tatiana
    Ostrozovicova, Miriam
    Kulcsarova, Kristina
    Cobejova, Jana
    Cobej, Martin
    Levicka, Petra
    Liesenerova, Simona
    Sendekova, Daniela
    Sukovska, Viktoria
    Gdovinova, Zuzana
    Han, Vladimir
    Rizig, Mie
    Houlden, Henry
    Skorvanek, Matej
    PARKINSONS DISEASE, 2022, 2022
  • [38] Fronto-parietal cortex activation during walking in patients with Parkinson's disease adopting different postural strategies
    Zhang, Xinyuan
    Wang, Yue
    Lu, Jiewei
    Wang, Jin
    Shu, Zhilin
    Cheng, Yuanyuan
    Zhu, Zhizhong
    Liu, PeiPei
    Yu, Yang
    Yu, Ningbo
    Han, Jianda
    Wu, Jialing
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [39] Altered regional homogeneity of prefrontal cortex in Parkinson's disease with mild cognitive impairment
    Kang D.-Z.
    Chen F.-X.
    Chen F.-Y.
    Liu Y.
    Wu G.
    Yu L.-H.
    Lin Y.-X.
    Lin Z.-Y.
    Chinese Neurosurgical Journal, 2 (1)
  • [40] Cost of illness and disease severity in a cohort of French patients with Parkinson's disease
    LePen, C
    Wait, S
    Moutaud-Martin, F
    Dujardin, M
    Ziégler, M
    PHARMACOECONOMICS, 1999, 16 (01) : 59 - 69